Article
Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models.
PloS one - 1 Jan 2022
Brown Brittney J, Boekell Kimber L, Stotter Brian R, Talbot Brianna E, Schlondorff Johannes S
Abstract excerpt
Mutations in TRPC6 are a cause of autosomal dominant focal segmental glomerulosclerosis in humans. Many of these mutations are known to have a gain-of-function effect on the non-specific cation channel function of TRPC6. In vitro studies have suggested these mutations affect several signaling pathways, but in vivo studies have largely compared wild-type and Trpc6-deficient rodents. We developed mice carrying a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
